Mutagenic Potential of Diphenylantimony Derivatives
Author Information
Author(s): Carmen Socaciu, Ioan Pasca, Cristian Silvestru, Adela Bara, Ionel Haiduc
Primary Institution: University of Agricultural Sciences, Cluj-Napoca
Hypothesis
Do diphenylantimony(III) derivatives exhibit mutagenic effects in mice?
Conclusion
Both diphenylantimony(III) compounds tested showed mutagenic potential, especially the phosphomdithioato derivative.
Supporting Evidence
- The study found a dose-dependent increase in micronuclei formation in treated mice.
- Both compounds were tested at two concentrations (10 and 20 mg/kg).
- Significant differences were observed compared to control groups.
- Compound 2 showed a higher mutagenic effect than compound 1.
- Micronuclei were identified as dark-blue-staining bodies in the cytoplasm of polychromatic erythrocytes.
- Chromosomal aberrations were more frequent in EAT-bearing mice treated with compound 2.
- Both the micronucleus test and metaphase analysis were used to evaluate mutagenicity.
- The results suggest a need for further studies to correlate short-term tests with long-term cancer studies.
Takeaway
The study tested two compounds on mice to see if they could cause mutations, and found that they might, especially one of them.
Methodology
The study used the micronucleus test and cytogenetic analysis on healthy and Ehrlich ascites tumor-bearing mice.
Limitations
The interpretation of the micronucleus test results remains difficult, and the limit between a positive and a negative result is not yet established.
Participant Demographics
Six-month-old AKR male mice were used.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website